Equity - Biotechnology
Now's a bad time to buy biotech...says Pictet biotech manager
Sector specialist says major market events could prove problematic.
Funds & Fund Managers
All calculations in EUR, unless stated
| Average Manager Total Return : 2.9% (30 June 2017 - 30 June 2018) | ||||
|---|---|---|---|---|
| Total Return | ||||
| 1 of 5 |
|
4.2% |
||
| 2 of 5 |
|
3.4% |
||
| 3 of 5 |
|
2.8% |
||
| 3 of 5 |
|
2.8% |
||
| 5 of 5 |
|
1.3% |
||
ESG managers raise alarm as Earth Overshoot Day is passed
Citywire rated managers and SRI chiefs explain where the priorities, risks and opportunities lie.
The three most improved banks and financials managers
Citywire looks at the sector specialists rising up the rankings over the past year.
The 10 equity managers taking in the most money over H1 2018
Citywire Investment Research looks at the inflows winners in the year so far.
‘Facebook's far from done’: inside Pictet star’s €2.6bn fund
Sylvie Sejournet reveals where she is positioning and why she isn't a simply a variation on the firm's giant robotics fund.
Pictet WM CIO's lesser-known ways of tapping themes
CIO Cesar Perez Ruiz reveals the group's edge on spotting themes.
This week on film: five videos you might have missed
Mobius, Hasenstab and more. Find out who sat down with Citywire Selector this week.